Funding opportunities
38 live opportunities from Grants.gov, NIH, NSF, and more.
Small Business (SBIR/STTR)× remove
- Fully recombinant, highly potent heptavalent botulinum antitoxin with ambient temperature stabilityNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $491,985activenih
- Ketogenic Approach to Restore Muscle in older patients with community-Acquired Pneumonia - KARMA-P TrialNational Institute on AgingPA-25-306 closes 5/31/2028up to $409,750activenih
- MetaDx: Rapid Diagnosis of Fungal, Bacterial, and Viral Infections Using Whole Metagenomic SequencingNational Institute of Allergy and Infectious DiseasesPA-24-245 closes 8/31/2027up to $295,294activenih
- The Development of a Personalized Feedback Program for Substance Use Disorder RiskNational Institute on Drug AbusePA-23-232 closes 5/31/2027up to $305,358activenih
- Addiction Application Gradebook: Fostering greater public health impact from mHealth applications for SUDNational Institute on Drug AbusePA-24-247 closes 5/31/2027up to $314,109activenih
- A Fully Integrated Platform for Reproducible and Scalable Single-Cell Sequencing in Clinical ResearchNational Institute of General Medical SciencesPA-24-245 closes 5/31/2027up to $382,798activenih
- A digital platform to address adverse effects resulting from non-disordered drug use, focused on mitigating serious mental illnessNational Institute on Drug AbuseRFA-DA-25-050 closes 5/31/2027up to $398,580activenih
- Development of ClusterBuild to Synthesize Biosynthetic Gene ClustersNational Institute of General Medical SciencesPA-24-245 closes 5/31/2027up to $306,151activenih
- Miniature Ion Mobility Detector for Compact Liquid Chromatographic Analysis of Novel Psychoactive SubstancesNational Institute on Drug AbuseRFA-DA-26-018 closes 5/31/2027up to $313,721activenih
- Clinical Decision Support for Early Detection of Relapse Risk in Adolescents with Substance Use DisordersNational Institute on Drug AbusePA-24-246 closes 5/31/2027up to $399,993activenih
- Treatment of CNS damage from non-disordered drug use with DRhQ, a novel regulator of CD74 signalingNational Institute on Drug AbuseRFA-DA-25-049 closes 5/31/2027up to $399,889activenih
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)National Institutes of HealthPA-27-100 closes 4/5/2027postedgrants.gov
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)National Institutes of HealthPA-27-102 closes 4/5/2027postedgrants.gov
Page 2 of 2